Serum samples from 154 patients with nasopharyngeal carcinoma (NPC), 374 with other cancers, 1,000 normal controls from Government Employees' Clinic Center (GECC), and 3,642 individuals of various ethnic-dialect groups living in high-risk areas for NPC were collected and the concentration of antibod
[Part 2: Biological Sciences] || Frequency and Levels of Antibodies to Epstein-Barr Virus-Specific DNase are Elevated in Patients with Nasopharyngeal Carcinoma
β Scribed by Yung-Chi Cheng, Jen-Yang Chen, Ronald Glaser and Werner Henle
- Book ID
- 123673480
- Publisher
- National Academy of Sciences
- Year
- 1980
- Tongue
- English
- Weight
- 557 KB
- Volume
- 77
- Category
- Article
- ISSN
- 0027-8424
- DOI
- 10.2307/9491
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We have examined serial sera from 17 juvenile patients with nasopharyngeal carcinoma (NPC) for their capacity to neutralize the activity of EpsteinβBarr virus (EBV)βspecific DNase. The results revealed that NPC patients who became longβterm survivors (LTS) without evidence of the diseas
A serological survey using antibody to Epstein-Barr virus (EBVI-specific DNase activity as a marker for the identification of patients with nasopharyngeal carcinoma (NPC) has been carried out on healthy subjects who visited Government Employees' Clinic Center (GECC) for routine health examination an
The feasibility of using elevated Epstein-Barr virus (EBV) specific-IgG antiviral capsid antigen (VCA) and IgA anti-VCA antibody levels as an aid in diagnosis of nasopharyngeal carcinoma (NPC) was analyzed by determination of serum antibody titers to EBV in 54 NPC patients, 114 healthy blood donors,